Literature DB >> 20350959

Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study.

Salvatore Lo Fermo1, Rita Barone, Francesco Patti, Patrizia Laisa, Tiziana L Cavallaro, Alessandra Nicoletti, Mario Zappia.   

Abstract

Psychiatric disturbances may occur at the onset of multiple sclerosis. However, information on their outcome is lacking. Our objective was to document the characteristics of psychiatric symptoms at presentation of multiple sclerosis and to define the long-term evolution of psychiatric disturbances in these patients. Based on a clinical record analysis of patients with defined multiple sclerosis diagnosis and coming under the care of a university multiple sclerosis centre within the period 1997-2007, patients with both psychiatric and neurological symptoms at presentation were identified. Clinical data at onset and at last follow-up were considered. Among 682 evaluated patients, psychiatric disturbances were associated with multiple sclerosis onset in 16 cases (2.3%). Most patients (56%) presented with a mood disorder with clinical characteristics of a major depressive-like episode, five (32%) had psychotic symptoms. Initial psychiatric disturbances improved later than neurological symptoms, or never fully recovered, regardless of the concomitant use of psychotropic medications. In most of the subjects psychiatric disturbances tended to remain over the follow-up period and at last visit, after a mean follow-up of 7.6 years (+/-2.3), 14 subjects (87%) had a supplementary diagnosis of psychiatric illness. Psychiatric symptoms at onset of multiple sclerosis may be indicators of possible maintenance of psychiatric morbidity in a sizeable proportion of patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20350959     DOI: 10.1177/1352458510365157

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  20 in total

1.  Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers.

Authors:  Andreea L Seritan; James A Bourgeois; Andrea Schneider; Yi Mu; Randi J Hagerman; Danh V Nguyen
Journal:  Curr Psychiatry Rev       Date:  2013-02

Review 2.  A Slice of the Suicidal Brain: What Have Postmortem Molecular Studies Taught Us?

Authors:  Daniel Almeida; Gustavo Turecki
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

3.  Comorbidities at multiple sclerosis diagnosis.

Authors:  Agnès Fromont; Christine Binquet; Fabien Rollot; Romain Despalins; Alain Weill; Laurence Clerc; Claire Bonithon-Kopp; Thibault Moreau
Journal:  J Neurol       Date:  2013-08-02       Impact factor: 4.849

4.  Psychotic reaction as a manifestation of multiple sclerosis relapse treated with plasma exchange.

Authors:  Tereza Gabelić; Ivan Adamec; Anamarija Mrđen; Milan Radoš; Vesna V Brinar; Mario Habek
Journal:  Neurol Sci       Date:  2011-07-28       Impact factor: 3.307

Review 5.  Psychiatric presentations/manifestations of medical illnesses.

Authors:  Jack Castro; Stephen Billick
Journal:  Psychiatr Q       Date:  2013-09

6.  An altered peripheral IL6 response in major depressive disorder.

Authors:  Kelli M Money; Zita Olah; Zeljka Korade; Krassimira A Garbett; Richard C Shelton; Karoly Mirnics
Journal:  Neurobiol Dis       Date:  2016-01-22       Impact factor: 5.996

7.  Major Depressive Disorder Following Dermatomyositis: A Case Linking Depression with Inflammation.

Authors:  Abhishek Reddy; Badari Birur; Richard C Shelton; Li Li
Journal:  Psychopharmacol Bull       Date:  2018-03-13

Review 8.  Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.

Authors:  Giulia Menculini; Elena Chipi; Federico Paolini Paoletti; Lorenzo Gaetani; Pasquale Nigro; Simone Simoni; Andrea Mancini; Nicola Tambasco; Massimiliano Di Filippo; Alfonso Tortorella; Lucilla Parnetti
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

9.  Mood disorder as the presenting manifestation of demyelination.

Authors:  D Tapos; L Sivaswamy
Journal:  Case Rep Neurol       Date:  2013-05-03

10.  Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis.

Authors:  Antonietta Gentile; Francesca De Vito; Diego Fresegna; Alessandra Musella; Fabio Buttari; Silvia Bullitta; Georgia Mandolesi; Diego Centonze
Journal:  Front Cell Neurosci       Date:  2015-06-25       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.